In the modern world, capitalism drives innovation, economic growth, and consumerism.
However, like any powerful system, it also has unintended consequences. One such
consequence is the growing threat of antibiotic resistance. The intersection of capitalist
forces and the spread of resistant bacteria offers a critical lens through which to
understand the current public health crisis.
The Capitalist Engine and Antibiotic Development
Antibiotics revolutionised medicine in the 20th century. Yet, the development of new
antibiotics has slowed significantly in recent decades. In a capitalist economy,
pharmaceutical companies prioritise profits, often leading to decisions that focus on
short-term gains. Antibiotics, which are typically used for a short period (compared to
chronic medications like statins or blood pressure drugs), are not as lucrative to develop.
As a result, pharmaceutical companies have diverted resources away from antibiotic
research toward more profitable ventures, such as lifestyle drugs and long-term treatment
options.
While there are still efforts to develop new antibiotics, they are often underfunded, with
few market incentives for major companies to pursue these drugs. This leaves the
healthcare system with limited tools to combat the rapid rise of resistant bacterial strains.
Mass Production, Overuse, and Misuse
Capitalism fosters mass production and mass consumption. This is particularly evident in
sectors such as agriculture, where antibiotics are frequently used to promote growth in
livestock and prevent diseases in densely packed farming environments. The overuse of
antibiotics in food production is a major factor contributing to the rise of resistant strains
of bacteria. When antibiotics are used on such a large scale, they create environments in
which bacteria can mutate and develop resistance, eventually making the drugs
ineffective for human use.
In human healthcare, the profit-driven healthcare system in many parts of the world also
contributes to the misuse of antibiotics. Physicians, often under pressure from patients
and influenced by pharmaceutical marketing, may prescribe antibiotics unnecessarily.
This misuse accelerates the development of resistant bacteria.
Global Inequities and Access to Medicine
Capitalism creates inequalities in access to healthcare, and these disparities extend to the
availability of antibiotics. In low- and middle-income countries, many individuals have
limited access to high-quality antibiotics, leading to the use of substandard or counterfeit
drugs. These drugs may not fully eradicate infections, giving bacteria a chance to develop
resistance.
On the other hand, in wealthier nations, antibiotics are often over-prescribed or used as a
precautionary measure, contributing to overuse. This imbalance highlights how capitalist
systems create a double-edged sword—both overuse and underuse can drive resistance
but for different reasons.
The Role of Governments and Regulation
In a capitalist framework, government intervention is often seen as a challenge to market
forces. However, the antibiotic resistance crisis demonstrates the need for regulatory
action. Governments can implement stricter policies on antibiotic use in agriculture,
incentivise pharmaceutical companies to invest in antibiotic research, and enforce
regulations to prevent over-the-counter antibiotic sales. Without these interventions, the
free market is unlikely to solve the antibiotic resistance crisis on its own.
Conclusion: A Path Forward
Capitalism, with all its strengths and weaknesses, has undoubtedly contributed to the rise
of antibiotic resistance. The system’s emphasis on profit maximisation has led to the
overuse of antibiotics in agriculture, the slowing of antibiotic innovation, and the unequal
access to life-saving drugs. Addressing this issue will require a concerted effort by
governments, pharmaceutical companies, and global organisations to prioritise public
health over short-term economic gains.
Without systemic change, the world risks entering a post-antibiotic era, where even minor
infections could once again prove deadly. A rethinking of the relationship between
capitalism and healthcare is essential to prevent this looming crisis from spiralling out of
control.